The etiology of breast cancer. Characteristic alteration in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk.
[BACKGROUND] Substantial hydroxyl radical (.OH)-induced base lesions, recently found in the DNA of invasive ductal carcinoma of the female breast, are likely to be intimately related to oncogenesis.
- Sensitivity 91%
- Specificity 97%
APA
Malins DC, Holmes EH, et al. (1993). The etiology of breast cancer. Characteristic alteration in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk.. Cancer, 71(10), 3036-43. https://doi.org/10.1002/1097-0142(19930515)71:10<3036::aid-cncr2820711025>3.0.co;2-p
MLA
Malins DC, et al.. "The etiology of breast cancer. Characteristic alteration in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk.." Cancer, vol. 71, no. 10, 1993, pp. 3036-43.
PMID
8387875
Abstract
[BACKGROUND] Substantial hydroxyl radical (.OH)-induced base lesions, recently found in the DNA of invasive ductal carcinoma of the female breast, are likely to be intimately related to oncogenesis. However, virtually no information was available regarding relationships between the different base lesions in the normal and cancerous breast. Such information is essential in understanding initial stages in the development of breast cancer and the potential of the base lesions as early predictors of cancer risk.
[METHODS] The .OH-induced DNA base lesions in normal reduction mammoplasty tissue (RMT) were compared with those from invasive ductal carcinoma (IDC) and nearby microscopically normal tissue (MNT). Comparisons were then undertaken on relationships between the base lesion profiles in the normal and cancerous breast using 22 statistical models.
[RESULTS] DNA from the RMT was characterized by a high ratio of ring-opening products (e.g., 4,6-diamino-5-formamidopyrimidine) to hydroxy-adducts of adenine and guanine. A dramatic shift in this relationship in favor of carcinogenic hydroxy-adducts (e.g., 8-hydroxyguanine) was found in the cancerous breast. Statistical models with a high sensitivity (91%) and specificity (97%) provided a consistent means of classifying tissues (e.g., 96% correct).
[CONCLUSIONS] The dramatic shift in the DNA base lesion relationships in oncogenesis is attributed to alterations in the redox potential of the breast favoring oxidative conditions and cancer formation. These findings suggest that base lesion profiles are potential sentinels for cancer risk assessment. Further, intervention in controlling the tissue redox potential may provide benefit in delaying or preventing early oncogenic changes and the ultimate manifestation of cancer.
[METHODS] The .OH-induced DNA base lesions in normal reduction mammoplasty tissue (RMT) were compared with those from invasive ductal carcinoma (IDC) and nearby microscopically normal tissue (MNT). Comparisons were then undertaken on relationships between the base lesion profiles in the normal and cancerous breast using 22 statistical models.
[RESULTS] DNA from the RMT was characterized by a high ratio of ring-opening products (e.g., 4,6-diamino-5-formamidopyrimidine) to hydroxy-adducts of adenine and guanine. A dramatic shift in this relationship in favor of carcinogenic hydroxy-adducts (e.g., 8-hydroxyguanine) was found in the cancerous breast. Statistical models with a high sensitivity (91%) and specificity (97%) provided a consistent means of classifying tissues (e.g., 96% correct).
[CONCLUSIONS] The dramatic shift in the DNA base lesion relationships in oncogenesis is attributed to alterations in the redox potential of the breast favoring oxidative conditions and cancer formation. These findings suggest that base lesion profiles are potential sentinels for cancer risk assessment. Further, intervention in controlling the tissue redox potential may provide benefit in delaying or preventing early oncogenic changes and the ultimate manifestation of cancer.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | breast
|
유방 | dict | 7 | |
| 시술 | reduction mammoplasty
|
유방성형술 | dict | 1 | |
| 해부 | DNA
|
scispacy | 1 | ||
| 해부 | tissue
|
scispacy | 1 | ||
| 해부 | tissues
|
scispacy | 1 | ||
| 합병증 | lesions
|
scispacy | 1 | ||
| 합병증 | base lesions
|
scispacy | 1 | ||
| 약물 | hydroxyl
|
C0063146
Hydroxyl Radical
|
scispacy | 1 | |
| 약물 | 4,6-diamino-5-formamidopyrimidine
|
C0047867
4,6-diamino-5-N-formamidopyrimidine
|
scispacy | 1 | |
| 약물 | adenine
|
C0001407
adenine
|
scispacy | 1 | |
| 약물 | guanine
|
C0018321
guanine
|
scispacy | 1 | |
| 약물 | 8-hydroxyguanine
|
C0050091
8-hydroxyguanine
|
scispacy | 1 | |
| 질환 | breast cancer
|
C0006142
Malignant neoplasm of breast
|
scispacy | 1 | |
| 질환 | ductal carcinoma of the female breast
|
C0007104
Female Breast Carcinoma
|
scispacy | 1 | |
| 질환 | cancer
|
C0006826
Malignant Neoplasms
|
scispacy | 1 | |
| 질환 | ductal carcinoma
|
C1176475
Ductal Carcinoma
|
scispacy | 1 | |
| 질환 | IDC
→ invasive ductal carcinoma
|
C1134719
Invasive Ductal Breast Carcinoma
|
scispacy | 1 | |
| 질환 | invasive ductal carcinoma
|
scispacy | 1 | ||
| 질환 | cancerous breast
|
scispacy | 1 | ||
| 질환 | MNT
→ microscopically normal tissue
|
scispacy | 1 |
MeSH Terms
Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; DNA Damage; Female; Humans; Hydroxides; Mammaplasty; Reactive Oxygen Species; Regression Analysis; Risk Factors
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
같은 제1저자의 인용 많은 논문 (1)
관련 논문
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Cutaneous fistula of the breast: A complication of cosmetic autologous fat transfer.
- Epidermal inclusion cyst after breast reduction mammoplasty.
- Clinical outcomes of synthetic absorbable mesh use in breast surgery: First case series in reconstruction and aesthetic mastopexy.
- Implant-based versus autologous mastopexy after massive weight loss: Complications and patient satisfaction.